Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion type Assertion NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_head.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion description "[Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 �g/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_provenance.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion evidence source_evidence_literature NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_provenance.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion SIO_000772 20477822 NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_provenance.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion wasDerivedFrom befree-2016 NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_provenance.
- NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_assertion wasGeneratedBy ECO_0000203 NP812682.RA7cyQlb0TF2rCRFk1Ighc_5_lPPyhQzFtwr0plFqRmjs130_provenance.